Trials / Active Not Recruiting
Active Not RecruitingNCT04865679
Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Axogen Corporation · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This pilot study evaluates the tolerability and feasibility of the Axoguard Large-Diameter Nerve Cap (sizes 5-7 mm) for protecting and preserving terminated nerve endings after limb trauma or amputation when immediate attention to the nerve injuries is not possible.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Axoguard Nerve Cap® | Entubulation of the nerve stump into the Axoguard Nerve Cap® following surgical excision of symptomatic neuroma |
Timeline
- Start date
- 2022-03-02
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2021-04-29
- Last updated
- 2025-05-02
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04865679. Inclusion in this directory is not an endorsement.